This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Further <i>N</i>-Frame networking dynamics of conscious observer-self agents via a functional contextual interface: predictive coding, double-slit quantum mechanical experiment, and decision-making fallacy modeling as applied to the measurement problem in humans and AI. [PDF]
Edwards DJ.
europepmc +1 more source
An‐nik‐a‐del. The History of the Universe as told by the Modesse Indians of California. C. H
A. L. Kroeber
openalex +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Retraction Note: A fixed support method for cryogenic silicon cavities of ultra-stable lasers for space applications. [PDF]
Meng F+6 more
europepmc +1 more source
Man's Physical Universe. Revised edition (Bawden, Arthur Talbot) [PDF]
C. S. Adams
openalex +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
Non-geodesic timelike observers and the ultralocal limit. [PDF]
Saadati R, Valsan L, Faraoni V.
europepmc +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
The use of metaverse in medical education: A systematic review. [PDF]
Li Q+5 more
europepmc +1 more source